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ABSTRACT
Objectives: The objective of the current research is to compare hormonal, metabolic and ovarian stromal blood flow 
outcomes in smoking versus non-smoking polycystic ovary syndrome (PCOS) patients. 
Material and methods: 79 PCOS women (Group 1) and 79 healthy subjects (Group 2) were recruited. Both groups were 
subdivided according to their smoking habits. Ovarian stromal blood flow was assessed with pulsatility and resistance 
index for both ovaries and compared among smoking women.
Results: The smokers in the PCOS group had statistically significant higher levels of pulsatility and resistance index in both 
ovaries compared to nonsmoker PCOS patients (p < 0.001). Comparison of ovarian stromal blood flow indexes shows that 
pulsatility and resistance index for both ovaries is statistically significantly high in smoking healthy patients compared to 
the nonsmoking group (p < 0.001). There is a positive correlation between smoking and free androgen index (r = 0.866, 
p < 0.001) for PCOS patients and healthy women.
Conclusions: Smoking reduces ovarian blood flow in PCOS patients and healthy subjects. Smoke components effect the 
vascular structure and form endothelial injuries that may reduce ovarian tissue perfusion. In this study, the positive cor-
relation between smoking and free androgen index shows that the main effect of smoking on ovarian blood flow may be 
through androgen metabolism.
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INTRODUCTION
Polycystic ovary syndrome (PCOS) was defined by Stein 
and Leventhal in 1935 and is characterized by hyperan-
drogenism, chronic anovulation and polycystic ovaries. It is 
a common endocrine disorder that affects 5–12% of women 
worldwide [1, 2]. Signs and symptoms of PCOS include obe-
sity, oligomenorrhea or amenorrhea, hirsutism and acne. 
PCOS can be diagnosed when two of the following three 
findings are present; anovulation, high levels of androgen 
and polycystic ovaries [3, 4]. The syndrome can also form 
comorbid diseases such as impaired insulin sensitivity, type 
II diabetes, hyperlipidemia, and cardiac illness [3, 4]. It is 
recommended that PCOS patients are screened for meta-
bolic syndrome and cardiovascular risk factors [5, 6]. Every 
women with PCOS should get advices on how to adjust 
style of living to prevent metabolic complications and car-
diovascular diseases. 
 The blood circulation of any organ is directly associated 
with its morphology and functions [7, 8]. In women with 
PCOS, it has been shown that significant changes have oc-
curred in vascularization of the ovarian stroma [7–10]. Batta-
glia et al. [7], Zaidi et al. [8], and Aleem et al. [9] established 
that, in cases with PCOS, important differences develop 
within the ovarian stroma circulation and they claimed that 
Doppler assays of ovarian stromal blood vessels may be 
useful for improving the investigation and could give more 
knowledge about the pathophysiology of the disease. In 
terms of systolic blood flow; there is a significant rise in the 
ovarian stromal velocities in women with PCOS compared 
to healthy women [7–11].
Clinical and experimental studies show that cigarette 
smoking alters the structures and functions of many organs 
and their blood circulation [12]. Based on the studies in the 
literature, the cigarette usage increases the incidence of car-
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diovascular diseases. Vasomotor dysfunction, inflammation 
and modifications of lipids, and the increase in androgen lev-
els may be the reasons for the progression of vascular lesions 
and atherosclerosis [13, 14]. There are studies in the litera-
ture showing the harmful effects of smoking on the vascular 
structures in the human body [12]. Kalfaoğlu et al. [15] as-
sessed the cerebral blood flow by carotid and vertebral artery 
Doppler ultrasonography and showed that smoking reduces 
the blood flow to the brain. Cigarette usage impairs the 
functions and vascularization of the genital organs [16, 17]. 
Reproductive organs are effected by cigarette smoking, such 
as an earlier onset of menopause, higher infertility risk and 
lower fecundity rate [16, 17]. Smoking is associated with 
endothelial dysfunction and an increase in arterial wall stiff-
ness, and there is evidence showing the smoking effect on 
the genital organs based on the measurement of the blood 
flow of uterine artery, clitoral artery and labia minora arter-
ies [17]. Nordenvall et. al. [18] and Albuquerque et al. [19] 
reported an increase in resistance index of the uterine artery 
in smoking women. In fact, no study has compared the effect 
of smoking on the ovarian doppler blood flow. 
The harmful effects of smoking on health have been 
proven in non-PCOS women, which makes the possible 
effects of smoking on hormonal changes, especially andro-
gens and ovarian blood flow changes in PCOS patients of 
interest [20]. The objective of the current study is to com-
pare hormonal, metabolic and ovarian stromal blood flow 
outcomes in smoking versus non-smoking PCOS patients. 
MATERIAL AND METHODS
The current prospective research was directed in the 
Division of Obstetrics and Gynecology at Near East Univer-
sity, Faculty of Medicine, Nicosia, Cyprus between Febru-
ary 2018 and June 2019. All participitants signed informed 
approval and local ethics committee accepted the study. 
All patients were young, nulliparous students from Near 
East University. Seventy-Nine PCOS women (Group 1) and 
79 healthy subjects (Group 2) were recruited for the study. 
Both groups were evaluated according to their smoking hab-
its. A total of 49 patients in the PCOS group and 39 women 
in the healthy group were smokers. Smoking was defined 
as 10 or more cigarettes per day. Medical and gynecologic 
patient history was asked from all the patients in the sample. 
The cases in group 2 had normal menstruation pattern and 
normal anatomical findings for baseline examination with 
transvaginal ultrasound. The diagnosis of PCOS was made ac-
cording to Rotterdam Consensus criteria [4]. Ferriman Galwey 
(FGS) scoring system was used to define hirsutism and abnor-
mal level of hirsutism was above 8. Exclusion aspects for the 
study were patient’s age being more than 35 years, positive 
bhcg test result, high prolactin levels, thyroid disfunctions, 
congenital adrenal hyperplasia, any surgical procedure of 
the ovary in the past or medication/systemic illnesses that 
may affect the mechanics in the hypothalamus and pituatry 
gland, abnormal androgen secretion, diabetes, hormonal 
therapy and combined oral contraceptive usage six months 
prior the research. In addition, detection of ovarian cyst or fol-
licle greater than ten milimeters or adnexial mass in a patients 
was accepted as elimination principle. Weight and height was 
measured by one clinician (Emekci Ozay O) at the begining 
to calculate body mass index (BMI). Blood sample analysis 
were done to measure the prolactin (PRL), thyroid stimulating 
hormone (TSH), follicle stimulating hormone (FSH), lutein-
izing hormone (LH), estradiol (E2), fasting glucose, fasting 
insulin, dehydroepiandrosterone sulfate (DHEAS), total and 
free testosterone, and sex hormone binding globulin (SHBG). 
Homeostatic model of insulin resistance (HOMA-IR) was used 
to determine insulin sensitivity. If the level of HOMA-IR as-
sessed was more than 2.5, it was defined as high resistancy 
in insulin. Free androgen index was calculated by the formula 
100x (Total testosterone/SHBG). During the initial five days 
of the menstruation, blood specimens were taken 8 hours 
afterwards abstaining. In women with no menstruation, after 
bhcg test analysis being negative, progesteron challenge 
test was performed with 5 mg/day medroxyprogesterone 
acetate (TARLUSAL; Deva Holding A.S.¸ Istanbul, Turkey). To 
check the ovarian blood flow, the doppler measurements 
were done during the third day of menstruation in the 
morning (08.00–11.00 am) by one operator (Ozay, A.C). The 
ultrasound machine used was Voluson 730Expert equipped 
with a 7–9 MHz transvaginal transducer. To avoid biases, clini-
cian performing the examination was blinded to the clinical 
and hormonal findings of the patients. All women emptied 
their urinary bladders before the ultrasound examination 
and they rested for at least 15 min before being scanned 
to diminish the outer factors on blood circulation. For the 
assesment of the stromal blood flow of the ovaries, color 
waves in the stroma were desired at a greatest expanse from 
the exteriors of the ovary. Blood vessels placed near to the 
surface of a follicle were not evaluated. Three serial analysis 
were performed and the mean utility was calculated for 
each factor. The pulsatility index (PI) and resistance index (RI) 
were otomatically documented by the ultrasound. Results 
are represented as mean ± standard deviation. Statistical 
Program for Social Sciences (SPSS) version 16 was used in 
the analysis. p < 0.05 is accepted as statistically significant.
RESULTS
A total of 158 patients’ results were analyzed. Group 1 
was formed from 79 PCOS patients, where 62% (n = 49) 
were smokers. Group 2 was formed from 79 healthy controls 
and cigarette usage in this group was 49.4% (n = 39). The 
comparison of the demographic characteristics, hormonal, 
metabolic status and ovarian stromal doppler findings of 
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PCOS and healthy group is shown in Table 1. The smokers 
in the PCOS group had statistically significant higher levels 
of pulsatility and resistance index in both ovaries compared 
to non-smoking PCOS patients. (Tab. 2). Comparison of 
ovarian stromal blood flow indexes showed that pulsatility 
and resistance index for both ovaries is statistically signifi-
cantly high in healthy smoking patients compared to the 
non-smoking group. (Tab. 3). Table 4 shows a comparison 
of the ovarian doppler indices of PCOS and healthy women 
who smoke. No statistically significant change was detected 
in ovarian blood flow between these groups. There was 
a positive correlation between the number of cigarettes 
consumed per day and free androgen index (r = 0.866, 
p < 0.001) (Fig. 1). Also, there was a positive correlation 
between total testosterone (r = 0.448, p < 0.001), free testos-
terone (r = 0.423, p < 0.001) and cigarettes smoked per day. 
SHBG (r = –0.454, p < 0.001) showed a negative correlation 
with cigarettes smoked per day.
DISCUSSION
There are rising opinions that PCOS women can have 
an elevated risk of vascular disorders in comparison with 
healthy women of an identical weiht and age. The rate of 
reproductive age women who smoke is as high as 30% and 
smoking increases the incidence of cardiovascular diseases 
and peripheral vascular disease [21, 22]. The present study 
focuses on the association between smoking and diverse 
ovarian stromal blood flow and its relations with cardiovas-
cular risks in PCOS patients and controls.
The results obtained in the current study confirm previ-
ous reports [21] of significantly higher BMI, LH/FSH ratio, 
circulating androgen values, insulin resistance and higher 
ovarian stromal blood flow in PCOS patients compared 
with healthy subjects. In 1995, Battaglia et al. showed that 
the existence of ovarian stromal vascularization with a de-
creased resistance index has great diagnostic worth for 
polycystic ovary syndrome [7]. Elevated levels of LH can be 
the cause for the marked up stromal vascularization by 
cytokine activation, catecholaminergic stimulation and 
neoangiogenesis [24]. Our study data supports that PCOS 
patients have lower right and left ovarian resistance index. 
The reduced PI and RI results are potential signals of the 
added on number and dilatation of ovarian stromal ves-
sels in PCOS [25]. Also, Agrawal et al. [26] claimed that in 
PCOS, an elevated level of vascular endothelial growth 
factor can be responsible for heightened ovarian stromal 
blood flow [26]. Similar to our analysis, many other studies 
in the literature show the increased ovarian blood flow as 
a common factor in PCOS compared to healthy women with 
normal menstrual cycles [7, 8, 11, 24, 27]. There are studies 
that show that insulin and insulin-like growth factor induce 
the angiogenesis and vasodilatation in the ovary, although 
Table 1. Comparison of hormonal, metabolic status and doppler findings of PCOS and healthy women
PCOS (n = 79) Control (n = 79) *p
Age [years] 21.76 ± 2.10 22.24 ± 2.27 0.168
BMI [kg/m2] 23.91 ± 4.55 22.14 ± 3.62 0.008
Waist/Hip Ratio 0.87 ± 0.20 0.68 ± 0.09 < 0.001
FGS 11.97 ± 4.58 4.05 ± 1.68 < 0.001
LH/FSH 1.60 ± 0.72 0.90 ± 0.27 < 0.001
Free T [pg/mL] 1.98 ± 0.67 0.89 ± 0.34 < 0.001
Total T [nmol/L] 1.66 ± 0.54 0.79 ± 0.27 < 0.001
FAI 4.52 ± 3.31 0.98 ± 0.46 < 0.001
DHEAS [ug/dL] 422.89 ± 134.91 207.59 ± 71.27 < 0.001
SHBG [nmol/L] 54.02 ± 29.62 87.43 ± 23.06 < 0.001
Androstenedione [ng/L] 130.48 ± 31.45 75.76 ± 15.68 < 0.001
HOMA-IR 1.87 ± 0.71 1.16 ± 0.43 < 0.001
Mean BP [mmHg] 87.80 ± 8.02 78.98 ± 7.81 < 0.001
LOPI 0.74 ± 0.23 0.86 ± 0.24 0.001
LORI 0.48 ± 0.13 0.54 ± 0.08 0.004
ROPI 0.70 ± 0.23 0.83 ± 0.18 < 0.001
RORI 0.50 ± 0.14 0.54 ± 0.07 0.026
BMI — Body mass index; FGS — Ferriman Gallwey score; LH — Luteinizing hormone; FSH — Follicle stimulating hormone; Free T — Free Testosterone; Total T — Total 
Testosterone; FAI — Free Androgen Index; DHEAS — Dehydroepiandrosterone sulphate; HOMA-IR — Homeostatic model for assessment of insulin resistance; 
Mean BP — Mean Blood Pressure; LOPI — Left ovarian pulsatility index; LORI — Left ovarian resistance index; ROPI — Right ovarian pulsatility index; RORI — Right 
ovarian resistance index. *p < 0.05 is statistically significant; Independent samples t test
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the certain pathway has not yet been explained [28]. In our 
study we found that insulin resistance and HOMA-IR values 
are higher in the PCOS group compared to healthy controls. 
When we evaluate the smoking effect on ovarian stromal 
blood flow in PCOS patients, we established that smoking 
increases the resistance and pulsatility index for right and left 
Table 2. Comparison of hormonal, metabolic status and doppler findings of smoking and non-smoking PCOS patients
Smokers (n = 49) Nonsmokers (n = 30) p
Age [years] 21.49 ± 1.65 22.20 ± 2.64 0.193
BMI [kg/m2] 23.75 ± 4.70 24.17 ± 4.35 0.697
Waist/hip ratio 0.86 ± 0.22 0.88 ± 0.18 0.788
LOPI 0.87 ± 0.20 0.53 ± 0.06 < 0.001
LORI 0.54 ± 0.12 0.40 ± 0.11 < 0.001
ROPI 0.81 ± 0.23 0.52 ± 0.08 < 0.001
RORI 0.56 ± 0.11 0.39 ± 0.12 < 0.001
LH/FSH 1.51 ± 0.66 1.74 ± 0.81 0.162
Free T [pg/mL] 2.03 ± 0.63 1.90 ± 0.72 0.405
Total T [nmol/L] 1.70 ± 0.51 1.58 ± 0.58 0.316
FAI 5.34 ± 3.67 3.18 ± 2.05 0.001
DHEAS [ug/dL] 430.10 ± 121.71 411.11 ± 155.57 0.571
SHBG [nmol/L] 48.61 ± 30.63 62.86 ± 26.02 0.031
Androstenedione [ng/dl] 126.09 ± 26.06 137.64 ± 38.09 0.150
HOMA-IR 1.80 ± 0.68 1.97 ± 0.75 0.310
Mean BP [mmHg] 86.48 ± 7.46 89.94 ± 8.56 0.063
BMI — Body mass index; FGS — Ferriman Gallwey score; LH — Luteinizing hormone; FSH — Follicle stimulating hormone; Free T — Free Testosterone; Total T — Total 
Testosterone; FAI — Free Androgen Index; DHEAS — Dehydroepiandrosterone sulphate; HOMA-IR — Homeostatic model for assessment of insulin resistance; 
Mean BP — Mean Blood Pressure; LOPI — Left ovarian pulsatility index; LORI — Left ovarian resistance index; ROPI — Right ovarian pulsatility index; RORI — Right 
ovarian resistance index; *p < 0.05 is statistically significant; Paired samples t test
Table 3. Comparison of hormonal, metabolic status and doppler findings of smoking and non-smoking healthy patients
Smokers (n = 39) Nonsmokers (n = 40) p
Age [years] 22.62 ± 2.60 21.88 ±  1.86 0.151
BMI [kg/m2] 22.08 ± 4.32 22.20 ± 2.83 0.876
Waist/hip ratio 0.67 ± 0.10 0.69 ± 0.08 0.361
LOPI 0.92 ± 0.25 0.81 ± 0.22 0.035
LORI 0.57 ± 0.08 0.51 ± 0.07 0.002
ROPI 0.89 ± 0.19 0.77 ± 0.15 0.002
RORI 0.56 ± 0.07 0.51 ± 0.06 0.003
LH/FSH 0.90 ± 0.27 0.89 ± 0.27 0.942
Free T [pg/mL] 0.96 ± 0.42 0.84 ± 0.21 0.103
Total T [nmol/L] 0.84 ± 0.30 0.74 ± 0.22 0.109
FAI 1.10 ± 0.54 0.86 ± 0.33 0.022
DHEAS [ug/dL] 208.38 ± 69.73 206.81 ± 73.62 0.922
SHBG [nmol/L] 84.92 ± 27.88 89.89 ± 17.15 0.345
Androstenedione [ng/dL] 75.35 ± 14.88 76.16 ± 16.60 0.821
HOMA-IR 1.12 ± 0.42 1.20 ± 0.44 0.411
Mean BP [mmHg] 79.37 ± 8.06 78.60 ± 7.64 0.664
BMI — Body mass index; LH — Luteinizing hormone; FSH — Follicle stimulating hormone; Free T — Free Testosterone; Total T — Total Testosterone; FAI — Free 
Androgen Index; DHEAS — Dehydroepiandrosterone sulphate; HOMA-IR — Homeostatic model for assessment of insulin resistance; Mean BP — Mean Blood Pressure; 
LOPI — Left ovarian pulsatility index; LORI — Left ovarian resistance index; ROPI — Right ovarian pulsatility index; RORI — Right ovarian resistance index; *p < 0.05 is 
statistically significant; Paired samples t test
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ovaries in smoking PCOS compared to non-smoking PCOS 
patients. In addition, according to our study data, cigarette 
usage decreases the blood flow in healthy controls by increas-
ing resistance and pulsatility index. Cigarette smoke causes 
blood vessels to increase stiffness, resistance, intima-media 
thickness, endothelial injury and decreases compliance and 
elasticity by increasing superoxide and endothelin-1 pro-
duction [29]. Çifti et al. [30], studied the smoking effect on 
vascular structures and they found that smoking-related he-
modynamic changes, endothelial dysfunction and increased 
stiffness were detected in subjects as young as 25 years of age. 
Battaglia et al. [17] showed that smoking reduces the blood 
flow in the genital organs in eumenorrheic women. For cases 
who use cigarrete for long time period, the vasoconstrictive 
outcomes of nicotine and the proatherogenic activity of dif-
ferent chemical components of smoke can cause a decreased 
perfusion in central and peripheral tissues [17]. 
Several studies have observed the effect of smoking 
in PCOS patients. This is the first research to observe the 
smoking effect on ovarian stromal blood flow in PCOS 
patients. Smoking may develop its effect of reducing the 
ovarian stromal blood flow in several ways. One possible 
route may be the increase in vascular stiffness, resistance 
and endothelial injury. Secondly, smoking may increase the 
androgen levels in blood circulation. Another influence of 
smoking could be its effect on insulin. However, in our study, 
we could not find any association between HOMA-IR values 
between smoking and nonsmoking PCOS patients. In fact, 
there was a significant increase in the free androgen index in 
smoking healthy women and PCOS patients. Also, there was 
a positive correlation between the number of cigarettes con-
sumed per day and the free androgen index. In women with 
PCOS, effect of smoking on clinical, metabolic and endocrine 
outcomes were evaluated by Cupisti et al. [31]. It was found 
that PCOS cases who were smoking showed increased free 
testosterone and rising insulin resistance. In terms of acne, 
ovulatory function and hirsutism they declared no change 
between non-smokers and smokers [31]. Funabashi et al. [32] 
found that in women who smoke, nicotine does not change 
the levels of LH. [32] This finding is correlated with our re-
search results and the LH/FSH ratio was not statistically 
significantly elevated in the smoking PCOS group compared 
to the non-smoker PCOS group in agreement with Cupisti el 
al. [31] The relation between androgens and nicotine can be 
associated with the metabolic route elaborated, as nicotine 
is mediated by cytochrome P450, which also plays a role in 
the biosynthesis of testosterone [33]. 
In our study, we also compared the smoking effect on 
ovarian stromal blood flow between PCOS and non-PCOS 
women. For both groups, ovarian stromal blood flow was 
reduced by smoking. The rate of decrease in the ovarian stro-
mal blood flow in both groups was similar, and no statisti-
cally significant change was observed. 
CONCLUSIONS
In conclusion, smoking reduces the ovarian stromal 
blood flow in PCOS and non-PCOS women. Nicotine has 
a vasoconstrictive effect and the endothelial injury of other 
smoke components may reduce ovarian tissue perfusion 
resulting in decreased ovarian stromal blood flow. In this 
study, the positive correlation between smoking and free 
Figure 1. Correlation graphic of free androgen index and cigarettes 
smoked per day
Table 4. Comparison of ovarian stromal doppler findings among smoking women
PCOS (n = 49) Control (n = 39) p
LOPI 0.87 ± 0.20 0.92 ± 0.25 0.259
LORI 0.54 ± 0.12 0.57 ± 0.08 0.221
ROPI 0.81 ± 0.23 0.89 ± 0.19 0.091
RORI 0.56 ± 0.11 0.56 ± 0.07 0.905
LOPI — Left ovarian pulsatility index; LORI — Left ovarian resistance index; ROPI — Right ovarian pulsatility index; RORI — Right ovarian resistance index; *p < 0.05 is 
statistically significant; Paired samples t test
Cigarette per day
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androgen index shows that the main effect of smoking on 
ovarian blood flow may be through androgen metabolism.
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